Template:Metoprolol: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Lopressor|{{fontcolor|#2B3B44|Lopressor (metoprolol tartrate) tablet}}]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Lopressor|{{fontcolor|#2B3B44|Lopressor (metoprolol tartrate) tablet}}]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor black box warning|Black Box Warning]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor indications and usage|Indications and Usage]]
Line 41: Line 43:
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Toprol XL|{{fontcolor|#2B3B44|Toprol XL (metoprolol succinate) tablet, extended release}}]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[Toprol XL|{{fontcolor|#2B3B44|Toprol XL (metoprolol succinate) tablet, extended release}}]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL black box warning|Black Box Warning]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Toprol XL indications and usage|Indications and Usage]]

Revision as of 14:59, 14 March 2014